Renal papillary carcinoma classification into subtypes may be reproduced by nuclear morphometry

Analytical and Quantitative Cytology and Histology

Volumn 31, Issue 2, 2009, Pages 109-117

  Okoń, Krzysztof ^a   Sińczak Kuta, Anna ^a   Stachura, Jerzy ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Chromatin texture; Clustering; Image analysis; Neural network; Papillary renal cell carcinoma

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MORPHOMETRICS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CELL NUCLEOLUS; CELL NUCLEUS; CELL NUCLEUS SHAPE; CELL NUCLEUS SIZE; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEURAL NETWORKS (COMPUTER); SENSITIVITY AND SPECIFICITY;

EID: 64549110213     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS: Papillary (chromophil) renal cell carcinoma: His- tomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997;21:621-635
2. Delahunt B, Eble JN: Papillary renal cell carcinoma: A clini-copathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10:537-544
3. Eble JN, Sauter G, Epstein JI: Tumours of the kidney. In World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Edited by JN Eble, G Sauter, JI Epstein. Lyon, IARC Press, 2004, pp 9-88
4. Soft-Imaging Software: Analysis imaging c. Soft-Imaging Software GmbH, Minister, Germany, 1996
5. Fleming S: The impact of genetics on the classification of renal carcinoma. Histopathology 1993;22:89-92
6. Renshaw AA: Subclassification of renal cell neoplasms: An update for the practising pathologist. Histopathology 2002; 41:283-300
7. Reuter VE: The pathology of renal epithelial neoplasms. Semin Oncol 2006;33:534-543
8. Mancilla-Jimenez R, Stanley RJ, Blath RA: Papillary renal cell carcinoma: A clinical, radiologic, and pathologic study of 34 cases. Cancer 1976;38:2469-2480
9. Corless CL, Aburatani H, Fletcher JA, Housman DE, Amin MB, Weinberg DS: Papillary renal cell carcinoma: Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol 1996; 5:53-64
10. Henke R, Erbersdobler A: Numerical chromosomal aberrations in papillary renal cortical tumors: Relationship with histopathologic features. Virchows Arch 2002;440:604-609
11. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124
12. Lubensky IA, Schmidt L, Zhuang Z, Weirich G, Pack S, Zambrano N, Walther MM, Choyke P, Linehan WM, Zbar B: Hereditary and sporadic papillary renal carcinomas with c- met mutations share a distinct morphological phenotype. Am J Pathol 1999;155:517-526
13. Wang KL, Weinrach DM, Luan C, Han M, Lin F, Teh BT, Yang XJ: Renal papillary adenoma: A putative precursor of papillary renal cell carcinoma. Hum Pathol 2007;38:239-246
14. Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ul-bright TM, Zhang S, Nigro K, Cheng L: Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res 2005;11:7226-7233
15. Füzesi L, Gunawan B, Bergmann F, Tack S, Braun S, Jakse G: Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p. Histopathology 1999;35:157-161
16. Salama ME, Worsham MJ, DePeralta-Venturina M: Malignant papillary renal tumors with extensive clear cell change: A molecular analysis by microsatellite analysis and fluorescence in situ hybridization. Arch Pathol Lab Med 2003;127: 1176-1181
17. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM: Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001;32:590-595
18. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ: Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: A Swiss experience with 588 tumors. Cancer 2000;89:604-614
19. Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debré B, Amsellem-Ouazana D: Survival analysis of 130 patients with papillary renal cell carcinoma: Prognostic utility of type 1 and type 2 subclassification. Urology 2007;69:230- 235
20. Gunawan B, von Heydebreck A, Fritsch T, Huber W, Ringert RH, Jakse G, Füzesi L: Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 2003;63:6200-6205
21. Sanders ME, Mick R, Tomaszewski JE, Barr FG: Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 2002;161: 997-1005
22. Furge KA, Chen J, Koeman J, Sw iatek P, Dykema K, Lucin K, Kahnoski R, Yang XJ, Teh BT: Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007;67:3171-3176
23. Yamanaka K, Miyake H, Hara I, Inoue T, Hanioka K, Fuji- sawa M: Papillary renal cell carcinoma: A clinicopathological study of 35 cases. Int J Urol 2006;13:1049-1052
24. Leroy X, Zini L, Leteurtre E, Zerimech F, Porchet N, Aubert JP, Gosselin B, Copin MC: Morphologic subtyping of papillary renal cell carcinoma: Correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002;15:1126-1130
25. Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chretien Y, Thiounn N, Dufour B: Prognostic factors for the survival of patients with papillary renal cell carcinoma: Meaning of histological typing and multifocalky. J Urol 2003;170:764-767
26. Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B: Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol 2006;30:1091-1096
27. Allory Y, Ouazana D, Boucher E, Thiounn N, Vieiiefond A: Papillary renal cell carcinoma: Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases. Vir- chows Arch 2003;442:336-342
28. Yang XJ, Tan M, Kim HL, Ditlev JA, Betten MW, Png CE, Kort EJ, Futami K, Furge KA, Takahashi M, Kanayama HO, Tan PH, Teh BS, Luan C, Wang K, Pins M, Tretiakova M, Anema J, Kahnoski R, Nicol T, Stadler W, Vogelzang NG, Amato R, Seligson D, Figlin R, Belldegrun A, Rogers CG, Teh BT: A molecular classification of papillary renal cell carcinoma. Cancer Res 2005;65:5628-5637
29. Jiang F, Richter J, Schraml P, Bubendorf L, Gasser T, Sauter G, Mihatsch MJ, Moch H: Chromosomal imbalances in papillary renal cell carcinoma: Genetic differences between histological subtypes. Am J Pathol 1998;153:1467-1473
30. Lefevre M, Couturier J, Sibony M, Bazille C, Bover K, Callard P, Viellefond A, Allory Y: Adult papillary renal tumor with oncocytic cells: Clinicopathologic, immunohistochemical, and cytogenetic features of 10 cases. Am J Surg Pathol 2005; 29:1576-1581
31. Hes O, Brunelli M, Michal M, Cossu Rocca P, Hora M, Chilosi M, Mina M, Boudova L, Menestrina F, Martignoni G: Oncocytic papillary renal cell carcinoma: A clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006;10:133- 139
32. Gortler J, Berghoff M, Kayser G, Kayser K: Grid technology in tissue-based diagnosis: Fundamentals and potential developments. Diagn Pathol 2006;1:23
33. 33.K ayser K, Radziszowski D, Bzdyl P, Sommer R: Towards an automated virtual slide screening: Theoretical considerations and practical experiences of automated tissue-based virtual diagnosis to be implemented in the Internet. Diagn Pathol 2006;1:10
34. Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA: Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res 2005;11: 5856-5862
35. Rubin MA, Zerkowski MP, Camp RL, Kuefer R, Hofer MD, Chinnaiyan AM, Rimm DL: Quantitative determination of expression of the prostate cancer protein alpha-methylacyl- CoA racemase using automated quantitative analysis (AQUA): A novel paradigm for automated and continuous biomarker measurements. Am J Pathol 2004;164:831-840
36. Kayser G, Radziszowski D, Bzdyl P, Sommer R, Kayser K: Theory and implementation of an electronic, automated measurement system for images obtained from immunohis- tochemically stained slides. Anal Quant Cytol Histol 2006; 28:27-38